Active and passive dosimetry for beta-emitting radiopharmaceutical therapy agents in a custom SPECT/CT compatible phantom.

Objective. This work introduces a novel approach to performing active and passive dosimetry for beta-emitting radionuclides in solution using common dosimeters. The measurements are compared to absorbed dose to water (Dw) estimates from Monte Carlo (MC) simulations. We present a method for obtaining absorbed dose to water, measured with dosimeters, from beta-emitting radiopharmaceutical agents using a custom SPECT/CT compatible phantom for validation of Monte Carlo based absorbed dose to water estimates.Approach. A cylindrical, acrylic SPECT/CT compatible phantom capable of housing an IBA EFD diode, Exradin A20-375 parallel plate ion chamber, unlaminated EBT3 film, and thin TLD100 microcubes was constructed for the purpose of measuring absorbed dose to water from solutions of common beta-emitting radiopharmaceutical therapy agents. The phantom is equipped with removable detector inserts that allow for multiple configurations and is designed to be used for validation of image-based absorbed dose estimates with detector measurements. Two experiments with131I and one experiment with177Lu were conducted over extended measurement intervals with starting activities of approximately 150-350 MBq. Measurement data was compared to Monte Carlo simulations using the egs_chamber user code in EGSnrc 2019.Main results. Agreement withink= 1 uncertainty between measured and MC predictedDwwas observed for all dosimeters, except the A20-375 ion chamber during the second131I experiment. Despite the agreement, the measured values were generally lower than predicted values by 5%-15%. The uncertainties atk = 1 remain large (5%-30% depending on the dosimeter) relative to other forms of radiation therapy.Significance. Despite high uncertainties, the overall agreement between measured and simulated absorbed doses is promising for the use of dosimeter-based RPT measurements in the validation of MC predictedDw.

Nuclear Medicine Imaging Procedures in Oncology.

Nuclear medicine radionuclide imaging is a quantitative imaging modality based on radioisotope-labeled tracers which emit radiation in the form of photons used for image reconstruction. Single photon emission computed tomography (SPECT) and positron emission tomography (PET) are the two noninvasive tomographic three-dimensional radionuclide imaging procedures for both clinical and preclinical settings. In this review on nuclear medicine imaging procedures in oncology, a variety of standard SPECT and PET tracers including radioiodine, 18Fluorine fluorodeoxyglucose (18F-FDG), and 68Gallium-labeled small proteins like Prostate Specific Membrane Antigen (PSMA) or somatostatin analogues and their application as targeted molecular imaging probes for improved tumor diagnosis and tumor phenotype characterization are described. Absolute and semiquantitative approaches for calculation of tracer uptake in tumors during the course of disease and during treatment allow further insight into tumor biology, and the combination of SPECT and PET with anatomical imaging procedures like computed tomography (CT) or magnetic resonance imaging (MRI) by hybrid SPECT/CT, PET/CT, and PET/MRI scanners provides both anatomical information and tumor functional characterization within one imaging session. With the recent establishment of novel molecular radiolabeled probes for specific tumor diagnosis, prognosis, and treatment monitoring, nuclear medicine has been able to establish itself as a distinct imaging modality with increased sensitivity and specificity.

Patient arm position during quantitative bone single-photon emission computed tomography/computed tomography acquisition can affect image quality and quantitative accuracy: a phantom study.

PURPOSE: The present study used a phantom to determine the effects of various arm positions on bone SPECT/computed tomography (CT) images and the optimal arm position to acquire good-quality and quantitatively accurate images. MATERIALS AND METHODS: We designed a phantom study of five simulated arm positions that are assumed during SPECT image acquisition. All SPECT data were acquired during a total of 120 projections of 10 and 100 s/view over 360° in a non-circular mode and reconstructed using Flash 3D (Siemens Healthineers). We evaluated contrast (QH,17 mm), image noise (NB,17 mm), contrast-to-noise ratios (QNRs), and visual scores according to the guidelines for bone SPECT acquisition protocols published by the Japanese Society of Nuclear Medicine Technology. The SUVmean, SUVmax, and SUVpeak were calculated and quantitative errors were evaluated using the recovery coefficient (RC) and the root means square error (RMSE). RESULTS: The spatial resolution of SPECT images was better when the arms were down than raised with simulated shoulder disorders. Raised arms with shoulder disorders significantly increased the NB,17 mm and decreased the QH,17 mm, and the QNR in each image differed over a range from 2.2 to 5.2. The visual score was >1.5 with the arms down, raised normally, and raised with moderate shoulder disorders. The SUVmax and SUVpeak were overestimated compared with 100-min data for all images, whereas SUVmean was underestimated. Raised arms with a shoulder disorder decreased RCmax, and RCmean and RCpeak suppressed differences among arm positions. In addition, RMSE with the arms down and raised normally were close to that for 100-min data. CONCLUSION: Bone SPECT images with good quality and quantitative accuracy can be acquired with patients holding their arms down by their sides. This will help patients with shoulder pain who have difficulties raising their arms.

The additional prognostic value of myocardial perfusion SPECT in patients with known coronary artery disease with high exercise capacity.

BACKGROUND: The prognostic value of myocardial perfusion imaging (MPI) in patients with known coronary artery disease (CAD) and high exercise capacity is still unknown. We sought to determine the MPI additional prognostic value over electrocardiography (ECG) stress testing alone in patients with known CAD who achieved ≥ 10 metabolic equivalents (METs). METHODS AND RESULTS: We evaluated 926 patients with known CAD referred for MPI with exercise stress. Patients were followed for a mean of 32.4 ± 9.7 months for the occurrence of all-cause death or nonfatal myocardial infarction (MI). Those achieving ≥ 10 METs were younger, predominantly male, and had lower prevalence of cardiovascular risk factors. Patients reaching ≥ 10 METs had a lower annualized rate of hard events compared to their counterparts achieving < 10 METs (1.13%/year vs 3.95%/year, P < .001). Patients who achieved ≥ 10 METs with abnormal scans had a higher rate of hard events compared to those with normal scans (3.37%/year vs 0.57%/year, P = .023). Cardiac workload < 10 METs and an abnormal MPI scan were independent predictors of hard events. CONCLUSIONS: MPI is able to stratify patients with known CAD achieving ≥ 10 METs for the occurrence of all-cause death and nonfatal MI, with incremental prognostic value over ECG stress test alone.

Estimation of CARE Dose 4D quality reference mAs conversion factors for child to adult reference patient in child protocols on Siemens Symbia SPECT-CT systems.

OBJECTIVES: CARE Dose 4D modulates mAs through several mechanisms according to patient size and shape, whilst maintaining user-defined reference image quality on Siemens Symbia single-photon emission computed tomography (SPECT)-computed tomography (CT) systems. A 20 kg child reference was used in child protocols prior to software version VB10 and a 75 kg adult thereafter. Quality reference mAs conversion factors are estimated for delivering equivalent mAs to children between two comparable SPECT-CT systems using adult and child references for topogram-based patient-size-related dose level adaptations. METHODS: A child phantom was scanned using child protocols on a Siemens Symbia T16 (child reference) and a Siemens Symbia Intevo Bold (adult reference). On each system, scans of the thorax, abdomen and pelvis were acquired with arms up and down, at 80 and 110 kVp. Quality reference mAs settings of 10-50 were used on the Symbia T16 and 40-200 on the Symbia Intevo Bold. These data were used to propose quality reference mAs (adult/child reference) conversion factors according to scan range, arm position and tube voltage. RESULTS: Quality reference mAs for child protocols using the adult reference should multiply the child quality reference mAs by the following factors, to give comparable delivered mAs: arms up 80 kV: 3.8 (thorax), 3.8 (abdomen), 4.3 (pelvis); arms up at 110 kV: 3.8 (thorax), 4.1 (abdomen), 4.6 (pelvis); arms down at 80 kV: 4.0 (thorax), 3.7 (abdomen), 3.9 (pelvis); arms down at 110 kV: 4.3 (thorax), 4.0 (abdomen), 4.2 (pelvis). CONCLUSION: Conversion factors for child to adult dose modulation references are proposed, allowing comparable delivered mAs to a child.Video abstract: http://links.lww.com/NMC/A178.

Feasibility of 177Lu Therapy Monitoring Using Fast Whole-Body SPECT Recordings Provided by a High-Speed 360° CZT Camera.

The whole-body absolute quantification of Lu-DOTATATE therapy was achieved using a high-speed 360° CZT SPECT/CT system. Twelve high-resolution swelling detectors may be positioned close to patients, providing a high-count sensitivity that is particularly advantageous for the low-count rate conditions of Lu imaging. After initially validating Lu quantification on phantom, serial whole-body SPECT/CT acquisitions of only 20 minutes were obtained for a 70-year-old woman treated by Lu-DOTATATE injections for a metastatic recurrence of a pancreatic neuroendocrine tumor. The progressive decrease in tumor uptake between the consecutive Lu-DOTATATE injections could be quantified, and thereby the corresponding dosimetry changes could be estimated.

Practical considerations for establishing dead-time corrections in quantitative SPECT imaging.

Quantitative SPECT studies require specific information about the equipment being used. Particularly in the context of therapeutic studies, the effect of dead-time can be significant and must be quantified. We explored different techniques for measuring the dead-time constant and applying dead-time corrections to the data. METHOD: The dead-time constant was measured on four similar SPECT/CT systems by following the response of the system to a uniform phantom initially containing 17 GBq of Lu-177 over a period of 23 days. It was then calculated using the two-source method with 1 332 MBq of Tc-99 m. The dead-time constant found was used to correct SPECT/CT phantom images either applying the correction by projection or globally on the image. RESULTS: Both methods of calculating the dead-time constant produced equivalent results. However, the dead-time constant varied by as much as 8% between machines of the same model and manufacturer. Correcting for dead-time by projection rather than globally produced slightly more precise results (0.94% error rather than 2.59% error). The benefit of this correction technique will be dependent on the level of asymmetry in the patient as well as the magnitude of the dead-time correction effect. CONCLUSION: quantification of the dead-time of a system can be performed quickly using the two-source method and any radioisotope. However, it is important to perform this measurement on every system being used. In vastly asymmetric images with high dead-time correction, correcting for dead-time by projection can be pertinent, increasing the precision of dosimetry calculations by several percent. However this additional gain may be within the error of SUV measurements for many clinical acquisitions.

First comparison of performances between the new whole-body cadmium-zinc-telluride SPECT-CT camera and a dedicated cardiac CZT camera for myocardial perfusion imaging: Analysis of phantom and patients.

BACKGROUND: Dedicated cardiac Cadmium-zinc-telluride (CZT) cameras show superior performances compared with Anger systems, particularly in terms of spatial resolution and count sensitivity. This study evaluated the performances of a new polyvalent whole body CZT camera (DNM 670CZT) compared with a cardiac dedicated CZT camera (DNM 530c) for myocardial perfusion SPECT. METHODS: The spatial resolution was evaluated with three linear sources filled with 99mTc. We used a cardiac phantom to evaluate count sensitivity, sharpness index, contrast-to-noise ratio, wall thickness, non-uniformity index, perfusion scores and ventricle volumes for both cameras. The impact of matrix size, and acquisition time was investigated. Concordance between the two cameras was evaluated in patients using QPS/QGS software for quantitative segmental perfusion, motion and thickness scores. RESULTS: The spatial resolution was identical with the two cameras. Count sensitivity of the DNM 670CZT was twofold lower compared with the DNM 530c, leading to lower sharpness index and contrast-to-noise ratio. The wall thickness and the myocardial volumes were similar. Visual and quantitative assessments of the perfusion patterns have shown a good concordance of the two cameras on phantoms and in patients. CONCLUSION: This study demonstrated the feasibility of myocardial perfusion SPECT imaging using the new whole-body DNM 670CZT camera.

Development and testing of SPECT/CT lung phantoms made from expanding polyurethane foam.

PURPOSE: Currently, single-photon emission computed tomography (SPECT)/computed tomography (CT) lung phantoms are commonly constructed using polystyrene beads and interstitial radioactive water. However, this approach often results in a phantom with a density (typically -640 HU) that is considerably higher than that of healthy lung (-750 to -850 HU) or diseased lung (-900 to -950 HU). Furthermore, the polystyrene and water phantoms are often quite heterogeneous in both density and activity concentration, especially when reused. This work is devoted to examining methods for creating a more realistic lung phantom for quantitative SPECT/CT using 99m Tc-laced expanding polyurethane foam (EPF). METHODS: Numerous aspects of EPF utilization were studied, including stoichiometric mixing to control final foam density and the effect of water during growth. We also tested several ways of molding the foam lung phantoms. The most successful method utilized a three-part silicone mold that allowed for creation of a two-lobe phantom, with a different density and activity concentration in each lobe. RESULTS: The final phantom design allows for a more anatomically accurate geometry as well as customizable density and activity concentration in the different lobes of the lung. We demonstrated final lung phantom densities between -760 and -690 HU in the "healthy" phantom and -930 to -890 HU in the "unhealthy" phantom tissue. On average, we achieved 15% activity concentration nonuniformity and 12% density nonuniformity within a given lobe. CONCLUSIONS: Final EPF lung phantoms closely matched the densities of both health and diseased lung tissue and had sufficient uniformities in both density and activity concentration for most nuclear medicine applications. Management of component moisture content is critical for phantom reproducibility.

Comparison between planar, SPECT and SPECT/computed tomography systems in 99mTc- nanocolloid sentinel lymph node imaging: phantom design and clinical investigations.

PURPOSE: It was aimed to examine the performance of planar, SPECT and SPECT/CT in lymph nodes detection of breast cancer. MATERIALS AND METHODS: In-house made phantom was immersed in water-filled container. Disparate activities were injected into spheres emulating breast tumour (1.5 cm), and adjacent lymph nodes (1, 0.5 and 0.25 cm). Planar, SPECT and SPECT/CT scans were made at depths of 1, 3, 5, 7 and 9 cm. Rose Criteria was employed to investigate the detectability in planar imaging, and contrast to noise ratios (CNRs) were used in SPECT and SPECT/CT images. SPECT and SPECT/CT of 20 patients were randomly incorporated in the current study. RESULTS: CNR values from planar images at 1 cm depth for the simulated nodes of 1, 0.5and 0.25 cm were 36, 18 and 17, respectively. Whereas, those from SPECT/CT were 94.5, 63.3 and 20.9, repectively. CNRs from SPECT were lower than SPECT/CT in order of 60.1, 41.8 and 17.1 at the same depth. At 9 cm, CNR values of 1, 0.5 and 0.25 cm from the planar images were 14, 6 and 5, respectively. While CNR values from SPECT were higher as 53.6, 38.0, and 14.9, respectively, and the greatest CNRs were in SPECT/CT as 85.7, 55.8, and 19.1, repectively. CONCLUSION: The CNR values in SPECT/CT were 1.5- and 3.5-folds higher than SPECT and planar imaging at depth range 1-9 cm. The patients study exhibited larger SPECT/CT CNRs over SPECT as great as 1.6-fold.

The clinical contribution of SPECT/CT with 99mTc-HMPAO-labeled leukocyte scintigraphy in hip and knee prosthetic infections. / Aportación clínica de la SPECT/TC en la gammagrafía con leucocitos marcados con 99mTc-HMPAO en infección de prótesis de cadera y rodilla.

OBJECTIVES: White blood cell scanning with 99mTc-hexamethylpropylene amine oxime (HMPAO) has proven a sensitive and specific imaging method in the diagnosis of suspected prosthesis infection. The aim of this retrospective study was to evaluate the usefulness of SPECT/CT performed simultaneously using a hybrid imaging device of prosthesis infections. MATERIALS AND METHODS: 99mTc-HMPAO scintigraphy was performed on 37 patients (11 men and 26 women; age range 38-84 years; mean age±SD, 65.7±5.6 years). Planar scans were acquired 2.4 and 24hour after injection. SPECT/CT was obtained 4 h after injection, using a dual-head hybrid gama camera coupled with a low-power x-ray tube. In all patients, scintigraphic results were matched with the results of surgery, cultures and clinical follow-up. RESULTS: Seventeen (45,9%) out of 37 patients had prosthesis infection and 20 (54,1%) out of 37 patients had non-infectious prosthesis pathologies with 99mTc-HMPAO scintigraphy and SPECT/CT. The 99mTc-HMPAO scintigraphy was true-positive for infection in 16 of 37 patients and true-negative in 20 of 37 patients. SPECT/CT provided an accurate anatomic localization of all positive foci. With regard to the final diagnosis, SPECT/CT added a significant clinical contribution in 22 of 37 patients (59,4%). Sensitivity, specificity, negative predictive value and positive predictive values were 100%,59.1%,100%,62.5% in planar images with 99mTc-HMPAO scintigraphy and 100%,90.1%,100%,88.2% in the planar+SPECT/CT imaging, respectively. DISCUSSION: Our results indicate that SPECT/CT performed using a hybrid device can improve imaging with 99mTc-HMPAO scintigraphy in patients with suspected osteomyelitis by providing accurate anatomic localization and precise definition of the extent of infection.

Ultrafast bone scintigraphy scan for detecting bone metastasis using a CZT whole-body gamma camera.

PURPOSE: To evaluate the feasibility of short whole-body bone scan acquisition times using a novel gamma camera with cadmium-zinc-telluride (CZT) semiconductor detectors. METHODS: We retrospectively enrolled 78 consecutive patients with prostate cancer who underwent bone scintigraphy using a whole-body gamma camera with CZT detectors. After acquisition of list-mode data with 180 s per bed position, anterior and posterior whole-body images were reconstructed using the first 5%, 10%, 25%, 50%, 75% and 100% of the list-mode data. Two experienced nuclear medicine physicians interpreted the images, and interrater agreement and the diagnostic value of the images were determined. Quantitative artificial neural network (ANN) values, bone scan indexes (BSI) and hotspot numbers (HsN) were also calculated by automated diagnostic software. RESULTS: Excellent interrater reliabilities of the visual assessments were obtained for the 100%, 75%, 50%, and 25% images (κ = 0.88, 0.88, 0.88 and 0.88, respectively). The 5% images also showed high diagnostic value (sensitivity 0.94, specificity 0.84 and accuracy 0.86). Intraclass correlation coefficients (ICC) between the 100% images and the reduced acquisition time images were evaluated in quantitative analyses, and excellent correlations were observed for ANN value in the 75% images (ICC 0.77), for BSI in all the reduced acquisition time images (75%, 50%, 25%, 10% and 5%; ICC 0.99, 0.99, 0.99, 0.96 and 0.75, respectively), and for HsN in the 75%, 50%, 25% and 10% images (ICC 0.99, 0.99, 0.98 and 0.90, respectively). CONCLUSION: Whole-body gamma cameras with CZT detectors have the potential to reduce image acquisition times and the dose of radioisotope injected for bone scans.

Impact of Mobile Phone Interference on Gamma Camera Performance.

INTRODUCTION: Electromagnetic interference (EMI) due to a mobile phone device has been reported to produce a detrimental effect on the function of a gamma camera system. This effect provides evidentiary support of potential bans or restrictions regarding mobile phone use within a nuclear medicine department. METHODOLOGY: A 3G Apple iPhone 6 was tested against a thyroid phantom in four operating modes, in three positions. Testing was carried out on a Siemens E-Cam gamma camera and a GE Discovery 670 SPECT/CT gamma camera. The protocols were standardized for operation on both systems with static images obtained for assessment. The static images were arithmetically assessed by means of subtraction from a baseline image, for results of potential EMI to be determined following comparison to the baseline image. RESULTS: Initial assessment of static images acquired provided no abnormality between modes and positions. Following the application of arithmetic processes, the inferior right lobe presented with an increased ring of activity on activation of mobile signals regardless of position when tested on the Siemens E-Cam gamma camera. When compared to the GE Discovery 670 SPECT/CT gamma camera, these results did not appear to be present. This was confirmed numerically as a statistical significant difference was noted in count differences between the Siemens E-Cam and GE Discovery (P = 0.0004). CONCLUSION: The function of a gamma camera has the potential to be influenced by EMI produced by mobile phone devices. Further investigation is warranted employing SPECT acquisition to assess the potential for amplification of errors.

Complications of shoulder arthroplasty: added value of SPECT/CT imaging. / Complicaciones de las prótesis de hombro: valor añadido de la imagen SPECT/TC.

The incidence of prosthetic shoulder replacements has increased considerably in recent years, as well as the complications derived from the procedure. The correct diagnosis of each type of complication is essential for therapeutic decision making, which is currently based on the information provided by radiological and nuclear medicine imaging. Nevertheless, both techniques have intrinsic limitations that could be mostly overcome with the advent of the hybrid SPECT/CT imaging, which is set to play a fundamental role in the evaluation of shoulder prostheses.

Advances in imaging instrumentation for nuclear cardiology.

Advances in imaging instrumentation and technology have greatly contributed to nuclear cardiology. Dedicated cardiac SPECT cameras incorporating novel, highly efficient detector, collimator, and system designs have emerged with the expansion of nuclear cardiology. Solid-state radiation detectors incorporating cadmium zinc telluride, which directly convert radiation to electrical signals and yield improved energy resolution and spatial resolution and enhanced count sensitivity geometries, are increasingly gaining favor as the detector of choice for application in dedicated cardiac SPECT systems. Additionally, hybrid imaging systems in which SPECT and PET are combined with X-ray CT are currently widely used, with PET/MRI hybrid systems having also been recently introduced. The improved quantitative SPECT/CT has the potential to measure the absolute quantification of myocardial blood flow and flow reserve. Rapid development of silicon photomultipliers leads to enhancement in PET image quality and count rates. In addition, the reduction of emission-transmission mismatch artifacts via application of accurate time-of-flight information, and cardiac motion de-blurring aided by anatomical images, are emerging techniques for further improvement of cardiac PET. This article reviews recent advances such as these in nuclear cardiology imaging instrumentation and technology, and the corresponding diagnostic benefits.

The effect of attenuation map, scatter energy window width, and volume of interest on the calibration factor calculation in quantitative 177Lu SPECT imaging: Simulation and phantom study.

PURPOSE: The objective of this study was to evaluate the image degrading factors in quantitative 177Lu SPECT imaging when using both main gamma photopeak energies. METHODS: Phantom measurements with two different vials containing various calibrated activities in air or water were performed to derive a mean calibration factor (CF) for large and small volumes of interest (VOIs). In addition, Monte Carlo simulations were utilized to investigate the effect of scatter energy window width, scatter correction method, such as effective scatter source estimation (ESSE) and triple energy window (TEW), and attenuation map on the quantification of 177Lu. RESULTS: The measured mean CF using large and small VOIs in water was 4.50 ±â€¯0.80 and 4.80 ±â€¯0.72 cps MBq-1, respectively. Simulations showed a reference CF of 3.3 cps MBq-1 for the water-filled phantom considering all photons excluding scattered events. By using the attenuation map generated for 190 keV photons, the calculated CFs for 113 keV and 208 keV are 10% lower than by using the weighted mean energy of 175 keV for 177Lu. The calculated CF using the TEW correction was 17% higher than using the ESSE method for a water-filled phantom. However, our findings showed that an appropriate scatter window combination can reduce this difference between TEW and ESSE methods. CONCLUSIONS: The present work implies that choosing a suitable width of scatter energy windows can reduce uncertainties in radioactivity quantification. It is suggested to generate the attenuation map at 113 keV and 208 keV, separately. Furthermore, using small VOIs is suggested in CF calculation.

Quality control in dual head gamma-cameras: Comparison between methods and software used for image analysis.

Patient radiation dose and image quality are primary issues in the conduct of nuclear medicine (NM) procedures. A range of protocols are currently used in image acquisition and analysis of quality control (QC) tests, with National Electrical Manufacturers Association (NEMA) methods and protocols widely accepted in providing an accurate description, measurement and report of γ-camera performance parameters. However, no standard software is available for image analysis. Present study compares vendor QC software analysis and three types of software freely downloadable from the internet: NMQC, NM Toolkit and ImageJ-NM Toolkit software. These were used for image analysis of QC tests of γ-cameras based on NEMA protocols including non-uniformity evaluation. Ten non-uniformity QC images were obtained using a dual head γ-camera installed in Trieste General Hospital and then analyzed. Excel analysis was used as the baseline calculation for the non-uniformity test according to NEMA procedures. The results of non-uniformity analysis showed good agreement between the independent types of software and Excel calculations (the average differences were 0.3%, 2.9%, 1.3% and 1.6% for the Useful Field of View (UFOV) integral, UFOV differential, Central Field of View (CFOV) integral and CFOV differential, respectively), while significant differences were detected following analysis using the company QC software when compared with Excel analysis (the average differences were 14.6%, 20.7%, 25.7% and 31.9% for the UFOV integral, UFOV differential, CFOV integral and CFOV differential, respectively). Compared to use of Excel calculations use of NMQC software was found to be in close accord. Variation in results obtained using the three types of software and γ-camera QC software was due to the use of different pixel sizes. It is important to conduct independent analyses tests in addition to using the vendor QC software in order to determine the differences between values.

CT-based attenuation correction and resolution compensation for I-123 IMP brain SPECT normal database: a multicenter phantom study.

OBJECTIVE: Statistical image analysis of brain SPECT images has improved diagnostic accuracy for brain disorders. However, the results of statistical analysis vary depending on the institution even when they use a common normal database (NDB), due to different intrinsic spatial resolutions or correction methods. The present study aimed to evaluate the correction of spatial resolution differences between equipment and examine the differences in skull bone attenuation to construct a common NDB for use in multicenter settings. METHODS: The proposed acquisition and processing protocols were those routinely used at each participating center with additional triple energy window (TEW) scatter correction (SC) and computed tomography (CT) based attenuation correction (CTAC). A multicenter phantom study was conducted on six imaging systems in five centers, with either single photon emission computed tomography (SPECT) or SPECT/CT, and two brain phantoms. The gray/white matter I-123 activity ratio in the brain phantoms was 4, and they were enclosed in either an artificial adult male skull, 1300 Hounsfield units (HU), a female skull, 850 HU, or an acrylic cover. The cut-off frequency of the Butterworth filters was adjusted so that the spatial resolution was unified to a 17.9 mm full width at half maximum (FWHM), that of the lowest resolution system. The gray-to-white matter count ratios were measured from SPECT images and compared with the actual activity ratio. In addition, mean, standard deviation and coefficient of variation images were calculated after normalization and anatomical standardization to evaluate the variability of the NDB. RESULTS: The gray-to-white matter count ratio error without SC and attenuation correction (AC) was significantly larger for higher bone densities (p < 0.05). The count ratio error with TEW and CTAC was approximately 5% regardless of bone density. After adjustment of the spatial resolution in the SPECT images, the variability of the NDB decreased and was comparable to that of the NDB without correction. CONCLUSION: The proposed protocol showed potential for constructing an appropriate common NDB from SPECT images with SC, AC and spatial resolution compensation.

Automated segmentation and detection of increased uptake regions in bone scintigraphy using SPECT/CT images.

PURPOSE: To develop a method for automated detection of highly integrated sites in SPECT images using bone information obtained from CT images in bone scintigraphy. METHODS: Bone regions on CT images were first extracted, and bones were identified by segmenting multiple regions. Next, regions corresponding to the bone regions on SPECT images were extracted based on the bone regions on CT images. Subsequently, increased uptake regions were extracted from the SPECT image using thresholding and three-dimensional labeling. Last, the ratio of increased uptake regions to all bone regions was calculated and expressed as a quantitative index. To verify the efficacy of this method, a basic assessment was performed using phantom and clinical data. RESULTS: The results of this analytical method using phantoms created by changing the radioactive concentrations indicated that regions of increased uptake were detected regardless of the radioactive concentration. Assessments using clinical data indicated that detection sensitivity for increased uptake regions was 71% and that the correlation between manual measurements and automated measurements was significant (correlation coefficient 0.868). CONCLUSION: These results suggested that automated detection of increased uptake regions on SPECT images using bone information obtained from CT images would be possible.

Optimizing Image Quantification for 177Lu SPECT/CT Based on a 3D Printed 2-Compartment Kidney Phantom.

The aim of this work was to find an optimal setup for activity determination of 177Lu-based SPECT/CT imaging reconstructed with 2 commercially available methods (xSPECT Quant and Flash3D). For this purpose, 3-dimensional (3D)-printed phantoms of different geometries were manufactured, different partial-volume correction (PVC) methods were applied, and the accuracy of the activity determination was evaluated. Methods: A 2-compartment kidney phantom (70% cortical and 30% medullary compartment), a sphere, and an ellipsoid of equal volumes were 3D printed, filled with 177Lu, and scanned with a SPECT/CT system. Reconstructions were performed with xSPECT and Flash3D. Different PVC methods were applied to find an optimal quantification setup: method 1 was a geometry-specific recovery coefficient based on the 3D printing model, method 2 was a geometry-specific recovery coefficient based on the low-dose CT scan, method 3 was an enlarged volume of interest including spilled-out counts, method 4 was activity concentration in the peak milliliter applied to the entire CT-based volume, and method 5 was a fixed threshold of 42% of the maximum in a large volume containing the object of interest. Additionally, the influence of postreconstruction gaussian filtering was investigated. Results: Although the recovery coefficients of sphere and ellipsoid differed by only 0.7%, a difference of 31.7% was observed between the sphere and the renal cortex phantoms. Without postfiltering, the model-based recovery coefficients (methods 1 and 2) resulted in the best accuracies (xSPECT, 1.5%; Flash3D, 10.3%), followed by the enlarged volume (method 3) (xSPECT, 8.5%; Flash3D, 13.0%). The peak-milliliter method (method 4) showed large errors only for sphere and ellipsoid (xSPECT, 23.4%; Flash3D, 21.6%). Applying a 42% threshold (method 5) led to the largest quantification errors (xSPECT, 32.3%; Flash3D, 46.7%). After postfiltering, a general increase in the errors was observed. Conclusion: In this work, 3D printing was used as a prototyping technique for a geometry-specific investigation of SPECT/CT reconstruction parameters and PVC methods. The optimal setup for activity determination was found to be an unsmoothed SPECT/CT reconstruction in combination with a recovery coefficient based on the low-dose CT. The difference between spheric and renal recovery coefficients suggests that the typically applied volume-dependent but only sphere-based recovery coefficient lookup tables should be replaced by a more geometry-specific alternative.